Picture of Magle Chemoswed Holding AB logo

MAGLE Magle Chemoswed Holding AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Magle Group Enters Into Merger Agreement To Buy Pk Biotech, Pk Chemicals

June 28 (Reuters) - Magle Chemoswed Holding AB
 MAGLE.ST :
    * ENTERS INTO MERGER AGREEMENT REGARDING THE ACQUISITION OF
PK
BIOTECH APS AND PK CHEMICALS A/S
    * PURCHASE PRICE FOR ALL SHARES IN PK BIOTECH WILL BE PAID
IN FORM
OF A SELLER PROMISSORY NOTE OF APPROXIMATELY SEK 240 MILLION
    * SELLER PROMISSORY NOTE WILL BE OFFSET AGAINST 7,200,000
NEWLY
ISSUED SHARES IN MAGLE GROUP
    * MERGER IS EXPECTED TO CREATE VALUE FOR SHAREHOLDERS OF NEW
MAGLE
GROUP THROUGH SYNERGIES
    * SYNERGIES SUCH AS NCREASED PRODUCTION CAPACITY, ENHANCED
CDMO
CAPABILITIES AND BROADENED SERVICE OFFERING
    * IN TOTAL, VALUE OF SYNERGIES FROM SUCH COST SAVINGS ARE
ESTIMATED TO AMOUNT TO BETWEEN SEK 7 MILLION AND 11 MILLION
ANNUALLY
    * SYNERGIES ARE EXPECTED TO BE UNLOCKED WITHIN 12 TO 24
MONTHS
    * ACQUISITION IS EXPECTED TO BE COMPLETED IN JULY 2024

Source text for Eikon:  ID:nMFN7PnX1P 
Further company coverage:  MAGLE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Magle Chemoswed Holding AB

See all news